Professional Documents
Culture Documents
Mucopolysaccharidoses data
Cristal Villalba
Advisor: Professor Ursula Matte
AGENDA
1) Who I am?
4) My projects
5) Other works
1/34
2/34
LYSOSOMES AND GLYCOSAMINOGLYCANS
(GAGS)
The lysosomes are responsible for the
degradation, and participate of several biological
processes
3/34
MUCOPOLYSACCHARIDOSES (MPS)
Mucopolysaccharidoses (MPS) are a group of rare genetic diseases when
defects of lysosomal enzymes responsible for the degradation of
glycosaminoglycans (GAGs), with progressive multisystemic involvement
(Fecarotta et al., 2020).
3/34
PATIENTS WITH MPS PRESENT SEVERAL PROGRESSI VE
MULTISYSTEMIC I NVOLVEMEN T IN SEVERAL TISSUES AND
ORGANS.
4/34
JUSTIFICATIVE
5/34
Manuscript 1
Fantastic Databases and where to find them: Web applications
for researchers in a rush
https://kur1sutaru.github.io/fantastic_databases_and_where_to_find_them/ 6/34
Manuscript 2
Neurological Impairment and Mucopolysaccharidoses: A system
biology approach
7/34
We did not include the GSE34071 -MPS VII (many different CNS tissues)
Manuscript 2-Results
9/34
https://www.ufrgs.br/mpsbase/
10/34
Manuscript 2 - Discussion
MPS I ontologies: autophagy, axon guidance, and vesicle trafficking - related to
neurodegeneration (Fecarotta et al., 2020); Notch1 - synaptic plasticity (Ables et
al., 2011)
MPS II ontologies: calcium signaling pathway - deranged in many LSD (Feng &
Yang, 2016); neuroactive ligand receptors pathway, calcium and insulin signalling
- cognitive decline in Alzheimer (Gomez-Ravetti et al., 2010).
MPS IIIB ontologies: TLR4 signaling, Innate Immune System, and Complement
activation (GSE23075) - Brain pathology (Parker & Bigger, 2019; Heon-Roberts et
al., 2020). Humoral immune response and B cell activation (GSE15758) -
according to DiRosario et al. (2009)
MPS VII ontologies: pathways common to MPS II; The Fc receptors (FcRs)
signaling - immune system - generates signals to the lysosomes and
proteasomes to initiate degradation of molecules (Molfetta et al., 2014)
11/34
Manuscript 2 - Conclusion
Receptors
Proteins GAGS
12/34
Manuscript 3
Lysosomal genes in neurological tumors: What’s that got to do
with lysosomal storage diseases?
14/34
Manuscript 3 - Results
15/34
GBM
LGG
16/34
LGG
GBM
17/34
18/34
Manuscript 3 - Discussion
CD68 are upregulated in GBM and IDH wt gliomas, and were correlated
with tumor-associated macrophages (Wang et al., 2018)
V-ATPase are related with IDHwt lower-grade gliomas and are associated
with glioma growth and serve as biomarker (Halcrow et al., 2019)
19/34
Manuscript 3 - Conclusion
We represented a comprehensive annotation of genomic alterations
status of a set of lysosomal related genes in neurological tumors,
specially in LGG and GBM.
21/34
METHODS
1 3 8
Cluego Cluepedia
DATASETS DATA ANALYSIS ENRICHMENT ANALYSIS
FROM MPS I, MPS II, MPS IIIA, MPS We use EdgeR for RNA-seq data, and For this work, we use the Cytoscape plugins
IIIB, MPS VI and MPS VII limma, oligo and affy for Microarray Bingo and Cluego/Cluepedia. To reduce the
data, according with the used
GO terms redundant, we use QuickGO.
platform
For more informations about the datasets, please visit our tool MPSBase:
https://www.ufrgs.br/mpsbase/
22/34
RESULTS
12 DATASETS
ONTOLOGIES THAT APPEARS
We found 680 oncogenic ontologies:
392 KEGG pathways IN ALL THE DATASETS
221 GO BP Hippo signaling pathway (hsa04390)
50 GO MF MAPK signaling pathway (hsa04010)
17 GO CC
23/34
DISCUSSION
25/34
CONCLUDING REMARKS
26/34
Manuscript 5
Repetitive Elements, Neurological damage and MPS
Cancer
Metabolic Diseases
Parkinson Disease
Alzheimer Disease
REMP
28/34
Manuscript 5 - Results
ARSB - MPS VI
Size: 208,879 bases
GC level: 41.00 %
Bases masked: 121464 bp ( 57.82 %)
29/34
Manuscript 5 - Results
ARSB - MPS VI
30/34
31/34
Manuscript 5 - Ongoing work
32/34
Manuscript 5 - Summary
We analyzed 56 lysosomal storage related genes, with a total of 6627 RE
The most abundant RE are the Alu family, according to Larsen et al. (2018)
We revised the literature about LSD and RE - 17 about LSD and 8 about MPS
33/34
34/34
References
Ables, J. L., Breunig, J. J., Eisch, A. J., & Rakic, P. (2011). Not(ch) just development: Notch signalling in the adult brain. Nature reviews.
Neuroscience, 12(5), 269–283. https://doi.org/10.1038/nrn3024
DiRosario, J., Divers, E., Wang, C., Etter, J., Charrier, A., Jukkola, P., Auer, H., Best, V., Newsom, D. L., McCarty, D. M., & Fu, H. (2009). Innate and
adaptive immune activation in the brain of MPS IIIB mouse model. Journal of neuroscience research, 87(4), 978–990.
https://doi.org/10.1002/jnr.21912
Fecarotta, S., Tarallo, A., Damiano, C., Minopoli, N., & Parenti, G. (2020). Pathogenesis of Mucopolysaccharidoses, an Update. International
journal of molecular sciences, 21(7), 2515. https://doi.org/10.3390/ijms21072515
Feng, X., & Yang, J. (2016). Lysosomal Calcium in Neurodegeneration. Messenger (Los Angeles, Calif. : Print), 5(1-2), 56–66.
https://doi.org/10.1166/msr.2016.1055
Gómez Ravetti, M., Rosso, O. A., Berretta, R., & Moscato, P. (2010). Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the
Changes of Hippocampus’ Gene Expression Profiles in Alzheimer’s Disease. PLoS ONE, 5(4), e10153. doi:10.1371/journal.pone.0010153
Heon-Roberts, R., Nguyen, A., & Pshezhetsky, A. V. (2020). Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of
Sanfilippo Disease. Journal of clinical medicine, 9(2), 344. https://doi.org/10.3390/jcm9020344
Le Joncour V, Filppu P, Hyvönen M, et al. (2019). Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO Mol
Med 11(6):e9034. doi:10.15252/emmm.201809034
Parker, H., & Bigger, B. W. (2019). The role of innate immunity in mucopolysaccharide diseases. Journal of neurochemistry, 148(5), 639–651.
https://doi.org/10.1111/jnc.14632
Tomatsu, S., Alméciga-Díaz, C. J., Montaño, A. M., Yabe, H., Tanaka, A., Dung, V. C., Giugliani, R., Kubaski, F., Mason, R. W., Yasuda, E.,
Sawamoto, K., Mackenzie, W., Suzuki, Y., Orii, K. E., Barrera, L. A., Sly, W. S., & Orii, T. (2015). Therapies for the bone in mucopolysaccharidoses.
Molecular genetics and metabolism, 114(2), 94–109.
Trejo-Solís, C; Serrano-Garcia, N; Escamilla-Ramírez, Á; Castillo-Rodríguez, RA; Jimenez-Farfan, D; Palencia, G; … Sotelo, J (2018). Autophagic and
Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma. Intern J Mol Sci , 19(12), 3773. doi:10.3390/ijms19123773
Walker, C., Mojares, E., & Del Río Hernández, A. (2018). Role of Extracellular Matrix in Development and Cancer Progression. International journal
of molecular sciences, 19(10), 3028. https://doi.org/10.3390/ijms19103028
Other works
Summary published in proceedings of conferences
SILVA, G. C. V.; MATTE, U. S. DOENÇAS LISOSSÔMICAS E GLIOMAS: O QUE ELES TÊM EM COMUM? 40a Semana Científica HCPA 2020.
https://postersc.hcpa.edu.br/;
SILVA, G. C. V.; MATTE, U. S. Cancer pathways are deranged in Mucopolysaccharidosis. 28th International Conference On Intelligent Systems for Molecular
Biology. 2020. <https://doi.org/10.7490/f1000research.1118053.1 >(Congress);
SILVA, G. C. V.; MATTE, U. S. Differential expression analysis of lysosomal storage-related genes in gliomas. Advances in Computational Biology
Conference 2019. <https://doi.org/10.7490/f1000research.1117674.1 >(Congress);
SANTOS, H. S. ; SILVA, G. C. V. ; BALDO, G. ; MATTE, U. S. . C HARACTERIZATION OF REPETITIVE ELEMENTS IN GENES ENCODING DIFFERENT
MUCOPOLYSACCHARIDOSES. In: XXXI Congresso Brasileiro de Genética Médica, 2019, Salvador. ANAIS CBGM 2019, 2019;
SILVA, G. C. V.; MATTE, U. S. Latin American School of Human and Medical Genetics.Autophagy and lysosomal regulation in Neurological tumors: What’s
that got to do with lysosomal storage diseases? 2019.
Awards
SILVA, G. C. V. Award of virtual ECCB2020 - New trends in Bioinformatics, European Student Council Symposium – 19th European Conference on
Computational Biology.
https://aime-registry.org/
Martiela,Cristal, and more people :P